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Introduction
The common causes of hypercalcaemia in cats are idio-
pathic hypercalcaemia,1 chronic kidney disease (CKD) 
and neoplasia.2 Other less common causes are primary 
hyperparathyroidism, granulomatous disease, hyper-
vitaminosis D and hypoadrenocorticism.
Hypervitaminosis D refers to toxicity resulting from 
calcidiol, calcitriol, cholecalciferol (vitamin D3) or ergo-
calciferol (vitamin D2). Iatrogenic causes in cats include 
excessive intake of vitamin D via dietary supplementa-
tion or treatment with vitamin D2, D3 or vitamin D 
metabolites.3 Toxic sources of vitamin D include certain 
plants, such as Jessamine, that contain glycosides of cal-
citriol, some rodenticides containing cholecalciferol and 
topical ointments for management of psoriasis contain-
ing vitamin D analogues.3
In contrast to humans, cats do not synthesise vitamin 
D in their skin in response to sunlight.4 Therefore, cats 
are dependent on dietary intake to obtain vitamin D and 
this nutrient is often supplemented in pet foods. Vitamin 
D in food can be found in the form of cholecalciferol and 
ergocalciferol. In the liver cholecalciferol is hydrolysed 
to 25-hydroxycholecalciferol (calcidiol), which is the 
major circulating form of vitamin D.3 In the kidney, 
25-hydroxycholecalciferol is further hydroxylated to 
1,25-dihydroxycholecalciferol (calcitriol), which is the 
biologically active form of vitamin D.3
Vitamin D influences calcium and phosphate absorp-
tion in the intestines and reabsorption in the kidneys. 
Therefore, excessive levels of vitamin D either from 
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exogenous or endogenous sources can result in hyper-
calcaemia. Hypervitaminosis D associated with inges-
tion of a complete commercial cat food containing 
excessive amounts of cholecalciferol has been previously 
reported.5
Case series description
Case 1
A 4-month-old female entire domestic shorthair cat pre-
sented to Highcroft Veterinary Referrals, Bristol, UK, 
with a 2 week history of mild lethargy, coughing, retch-
ing and vomiting. Melaena and pica were also described. 
A course of amoxicillin-clavulanate (Clavaseptin; 
Vetoquinol), fenbendazole (Panacur; MSD Animal 
Health) and a long-acting antibiotic injectable prepara-
tion (cefovecin; Convenia, Zoetis) had been adminis-
tered prior to referral, to which the owner reported no 
response. There was no history of plant ingestion or 
toxin exposure including rodenticides or psoriasis oint-
ments. The cat had no outdoor access. The cat was fed ad 
libitum complete dry kitten food supplemented with a 
natural complementary tinned kitten food produced by 
the same pet food manufacturer. In addition, the cat was 
given kitten milk. No other foods were fed.
On clinical examination, the cat was coughing and 
retching frequently and there was a positive tracheal 
pinch response. Pulmonary auscultation revealed dif-
fuse mild wheezing. The cat was underconditioned 
(body condition score [BCS] 3/9, body weight 1.51 kg).
Haematology performed 5 days prior to referral 
revealed a microcytosis (mean corpuscular volume 
[MCV] 38.1 fl; reference interval [RI] 40–55 fl) that was 
considered related to chronic gastrointestinal bleeding 
given the melaena and pica; the packed cell volume 
(PCV) was normal (34%; RI 27–50%). Serum biochemis-
try performed 5 days prior to referral revealed increased 
urea (15.0 mmol/l; RI 6.0–10.0) and a marked total 
hypercalcaemia (4.68 mmol/l; RI 1.60–3.00 mmol/l). 
Serum phosphate was at the upper limit of the RI (2.56 
mmol/l; RI 1.40–2.60 mmol/l) (see Table 1). Mild 
increases in alanine transferase (ALT) and alkaline phos-
phatase (ALP) activity and cholesterol were present 
(ALT 81I U/l [RI 0–20 IU/l]; ALKP 46 IU/l [RI 0–40 
IU/l]; cholesterol 4.2 mmol/l [RI 1.9–3.9 mmol/l]). Blood 
ELISA testing for feline leukaemia virus antigen and 
feline immunodeficiency virus antibody was negative. 
In-house urinalysis revealed a specific gravity of 1.016. A 
urine dipstick showed trace protein, a pH of 5 and was 
otherwise unremarkable.
Abdominal ultrasonography revealed reduced renal 
corticomedullary definition bilaterally and a slightly 
hyperechoic gastric wall considered to be consistent 
with mineralisation. CT imaging of the thorax revealed 
circumferential mineralisation of the aortic root, aortic 
arch and brachiocephalic trunk (see Figure 1). There was Ta
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a diffuse interstitial hyperattenuation of the pulmonary 
parenchyma (see Figure 2) consistent with pulmonary 
mineralisation, pulmonary oedema, pulmonary fibrosis 
or inflammation. The nasopharynx, oral cavity, pharynx 
and larynx were unremarkable. Pharyngeal swabs for 
feline herpesvirus-1 and calicivirus PCRs were negative. 
The airways had a normal appearance on bronchoscopy. 
Echocardiography was unremarkable. Following these 
investigations and pending results the cat was dis-
charged with a course of doxycycline (13 mg/kg q24h 
PO [Ronaxan 20 mg tablets; Merial]).
Cytology of bronchoalveolar lavage (BAL) samples 
revealed a highly cellular sample with a mixed inflamma-
tory population (62% macrophages, 32% neutrophils and 
6% eosinophils) and no visible microorganisms. Bacterial 
culture of BAL fluid (BALF) revealed a growth of contami-
nant only (non-lactose fermenting coliform). Mycoplasma 
species PCR of BALF was positive. Bordetella bronchiseptica 
PCR of the BALF was negative. Faecal analysis (Baermann’s) 
was negative making lungworm infection unlikely.
Differential diagnoses at this stage included idio-
pathic hypercalcaemia, CKD and vitamin D toxicity. 
Granulomatous disease or neoplasia had initially been 
considered as potential causes given the presenting res-
piratory signs and pulmonary findings; however, these 
were considered unlikely given the test results. Primary 
hyperparathyroidism and hypoadrenocorticism were 
considered unlikely owing to lack of other supportive 
clinical findings. Furthermore, these would be very 
rare in cats.
The cat re-presented on day 7 and was reported to be 
brighter with reduced but persistent coughing and retch-
ing and resolution of vomiting and melaena. Serum 
biochemistry was repeated and measurement of ionised 
calcium confirmed persistent hypercalcaemia (see 
Table  1). Body weight and condition score were stable 
(1.56 kg and 3/9, respectively).
Blood samples were submitted for parathyroid hor-
mone (PTH), PTH-related protein (PTH-rP) and vitamin 
D metabolite analysis, prior to treatment for hypercal-
caemia. PTH and PTH-rP were within the reported nor-
mal laboratory RIs (see Table 2), allowing exclusion of 
primary hyperparathyroidism and making neoplasia a 
less likely diagnosis. Both calcidiol and calcitriol concen-
trations were markedly increased (see Table 2). These 
findings were consistent with a diagnosis of hypervita-
minosis D.
The cat was admitted to the hospital and intravenous 
(IV) fluid therapy (IVFT) was administered (0.9% NaCl, 
2 ml/kg/h). In addition, IV furosemide (2 mg/kg q8h 
[Dimazon 50 mg/ml solution for injection; MSD]) and 
oral prednisolone (0.6 mg/kg q12h [Prednicare 1 mg tab-
lets; Animalcare]) were initiated. Doxycycline was con-
tinued owing to the positive PCR for Mycoplasma species 
on the BAL sample. The diet was changed to an alterna-
tive complete kitten food only. The ionised hypercalcae-
mia persisted despite this therapy; therefore, on day 11 
an IV infusion of pamidronate was administered over 4 
h (total dose 1 mg diluted in 0.9% NaCl [Aredia 15 mg 
powder for reconstitution; Novartis Pharmaceuticals 
UK]). Subsequently IV furosemide was transitioned to 
oral furosemide (Frusol 40 mg/ml oral suspension; 
Rosemount Pharmaceuticals) at the same equivalent 
dose. The cat responded to the pamidronate with a 
steady decrease in ionised calcium concentration with 
Figure 1 CT image of the thorax of a hypercalcaemic cat 
(case 1) revealed circumferential mineralisation of the aortic 
root (arrow)
Figure 2 CT image of the thorax of a hypercalcaemic cat 
(case 1) revealed diffuse interstitial hyperattenuation of the 
pulmonary parenchyma
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return to normocalcaemia by day 14 (see Table 1). The cat 
was discharged on day 14 with doxycycline (13 mg/kg 
q24h PO), furosemide solution (1.3 mg/kg q12h PO) and 
prednisolone (0.6 mg/kg q12h PO). In addition, the 
owner was advised to make a dietary change at home to 
an alternative high-quality complete kitten food with no 
additional supplements or complementary foods.
On day 17, the owner reported complete resolution of 
all the presenting clinical signs. Clinical examination 
was unremarkable and weight gain had occurred (body 
weight 1.7 kg, BCS score 5/9). Blood testing confirmed 
normocalcaemia (ionised calcium). Doxycycline and 
furosemide were discontinued and prednisolone was 
tapered to 0.6 mg/kg q24h for a further week and then 
discontinued.
Repeat haematology on day 31 revealed a stable 
microcytosis (MCV 37.9 fl; RI 40–55 fl) with a normal 
PCV (29%; RI 27–50%). Repeat serum biochemistry 
showed normocalcaemia and no abnormalities (see 
Table 1). Repeat thoracic CT imaging revealed resolution 
of the pulmonary interstitial hyperattenuation and 
improvement in the arterial mineralisation. It was sus-
pected that the pulmonary interstitial hyperattenuation 
was due to metastatic mineralisation with secondary 
inflammatory infiltrate that had resolved with control of 
the hypercalcaemia. The Mycoplasma species infection 
may also have played a role.
To determine a cause for the hypervitaminosis D, die-
tary analysis of the foods fed was performed at an inde-
pendent, external, commercial laboratory (Heartland 
Assays, Ames, IA, USA). Results are presented in Table 3 
and confirmed the presence of a toxic amount of vitamin 
D in the complementary tinned kitten food.
Cases 2 and 3 (related siblings)
Two British Shorthair siblings (male case 2 and female 
case 3, both 5 months old and entire) presented to The 
Feline Centre, Langford Vets, University of Bristol, UK, 
with a 1 week history of lethargy and inappetence and a 4 
day history of polydipsia and polyuria. The cats had ini-
tially presented to the referring veterinary practice 2 days 
previously, at which time serum biochemistry had docu-
mented a marked total hypercalcaemia (>4 mmol/l; RI 
1.98–2.83 mmol/l) in both cats. In-house haematology 
and serum biochemistry had also demonstrated mild ele-
vations in urea (case 2: 14.4 mmol/l; case 3: 16.2 mmol/l 
[RI 5.7–11.8 mmol/l]) and PCVs (case 2: 38.7%; case 3: 
41.7% [RI 24.8–37.5%]), consistent with dehydration.
Table 2 Parathyroid hormone (PTH), PTH-related protein (PTH-rP) and vitamin D metabolite concentrations in a 
hypercalcaemic, 4-month-old female entire domestic shorthair cat (case 1)
Case 1 RI
PTH 1.6 <4.2 pmol/l
PTH-rP 0.3 <0.5 pmol/l
1,25 Dihydroxyvitamin D (calcitriol) >438 192–317 pmol/l
25-Hydroxyvitamin D (calcidiol) 2230 65–170 nmol/l
Ionised calcium 2.02 1.10–1.40 mmol/l
References intervals (RIs) for PTH, PTH-rp and calcidiol were provided by the diagnostic laboratory performing sample analysis for PTH, PTH-rP 
and calcidiol. The RI for calcitriol was not provided and was taken from a previous study,6 derived from healthy age-matched control cats
Table 3 Dietary analysis of all foods fed prior to referral to a hypercalcaemic 4-month-old female entire domestic 
shorthair cat (case 1)
Vitamin D2 
declared
Vitamin D2 
measured
Vitamin D2 
measured 
(DM 
basis)*
Vitamin D3 
declared
Vitamin D3 
measured
Vitamin D3 
measured 
(DM basis)*
Combined 
vitamin D2 
and D3 
measured
Combined 
vitamin D2 
and D3 
measured 
(DM basis)*
Tinned kitten 
food (IU/kg)
None 9848 54,711 None 49,737 276,316 59,585 331,027
Dry kitten 
food (IU/kg)
None 616 670 1200 2105 2288 2721 2958
Kitten milk 
(IU/l)
None 8 58 220 84 612 92 670
See Table 8 for recommended concentrations
*Dry matter (DM) was calculated from the declared moisture content of the tinned food (82%), dry food (8%) and kitten milk (86.3%), and was 
not measured directly
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An abdominal ultrasound had been performed at the 
referring veterinary practice by a board-certified imag-
ing specialist. Case 2 was documented to have promi-
nent renal corticomedullary differentiation and a 
medullary rim sign bilaterally, which were considered to 
be clinically insignificant. Case 3 was found to have a 
large amount of ingesta in the stomach and gas in the 
intestines. The remainder of the examination was nor-
mal and there was no evidence of soft tissue mineralisa-
tion or uroliths.
At referral, a full clinical history was obtained. There 
was no history of ingestion or access to vitamin D con-
taining plants or products. Dietary history revealed that 
both cats were fed a variety of complete wet and dry cat 
foods, supplemented by the same complementary natu-
ral tinned kitten food fed to case 1, and occasional treats. 
On physical examination, both cats were bright, alert 
and responsive, and were in good body condition (case 2 
BCS 5/9, body weight 2.24 kg; case 3 BCS 5/9, body 
weight 1.86 kg). Physical examination of both cats was 
unremarkable, with the exception of a grade II/VI sys-
tolic heart murmur detected in case 2.
Venous blood gas and electrolyte analysis at admis-
sion confirmed ionised hypercalcaemia in both cats (see 
Tables 4 and 5). Haematology and biochemistry were not 
performed at admission as they had recently been per-
formed at the referring vets. Urinalysis (following initia-
tion of IVFT) revealed case 2 to have a urine specific 
gravity (USG) of 1.033, mild (1+) calcium oxalate crys-
talluria and a urine protein to creatinine (UPC) ratio of 
0.14 (RI <0.4). Case 3 had a USG post-IVFT of 1.012, UPC 
of 0.22 and scant squamous epithelial cells, scant white 
blood cells and scant struvite crystals on sediment exam-
ination (small bladder size on admission prevented col-
lection of samples before fluid therapy).
Thoracic and abdominal radiographs of both cats 
were unremarkable with no evidence of metastatic 
mineralisation. Additionally, echocardiographic exami-
nation was performed in case 2 and showed an inciden-
tal flow murmur, not considered to be of clinical 
significance.
PTH, vitamin D metabolites and calcitonin were 
measured in both cats (see Table 6). PTH-rP was not 
measured owing to limited suspicion of neoplasia con-
sidering the age and presentation of the cats and to 
insufficient sample volume. PTH, calcitriol, calcidiol and 
calcitonin were measured using previously validated 
assays.7–9 Calcitriol and calcidiol were increased in both 
cats confirming hypervitaminosis D. Vitamin D toxicity 
was suspected to be the underlying cause of this. 
Calcitonin concentration was undetectable in both cats.
The cats were initially managed for hypercalcaemia 
with IVFT (0.9% NaCl, 4 ml/kg/h); however, ionised 
calcium concentrations remained persistently elevated 
(see Tables 4 and 5). Therefore, prednisolone (2.5 mg/
Ta
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cat q12h PO [Prednidale 5 mg; Dechra Pharmaceuticals]) 
and furosemide (5 mg/cat q12h PO; generic preparation) 
were incorporated into the management. Following this 
(day 5), the ionised calcium concentration in case 3 nor-
malised and furosemide administration was discontin-
ued and the prednisolone was gradually tapered and 
discontinued (see Table 5). In case 2, the hypercalcaemia 
persisted and additional management with psyllium 
husk (Fybogel powder [Reckitt Benckiser Healthcare]; 
1/4 teaspoon q6h mixed with food PO) was prescribed 
in order to promote intestinal binding of calcium (see 
Table 4).
The cats were discharged on day 12. In case 2, medica-
tions prescribed as above were continued until normo-
calcaemia was achieved at day 18 when these were 
gradually tapered and discontinued (see Table 4). Case 3 
was discharged without medication.
Cases 2 and 3 were fed the same complementary 
tinned kitten food as part of their diet as case 1. Dietary 
analysis of this complementary diet was performed. The 
complementary natural kitten food was submitted to an 
independent, external, commercial laboratory (ALS 
Food and Pharmaceutical, Ely, UK) for quantification of 
calcium, phosphorus, vitamin D and moisture levels. 
Results showed markedly excessive vitamin D levels 
(Table 7).
Discussion
This case series describes three cases of vitamin D toxico-
sis in young cats that presented with hypercalcaemia, in 
which a natural complementary tinned kitten food that 
contained excessive vitamin D concentrations was fed as 
part of the diet. In case 1, a dry complete food from the 
same manufacturer was also fed to the cat. The meas-
ured vitamin D content in this dry food was over twice 
the declared amount of added vitamin D and also above 
the legal limit for declared additives (see Tables 2 and 8). 
The tinned complementary food label stated that there 
were no additives; ingredients were listed as chicken 
breast (53%), rice and minerals. As there is no legal limit 
for the amount of naturally occurring vitamin D in cat 
foods, the nutritional maximum rather than legal limit 
should be considered when interpreting the dietary 
analysis of the tinned food. In all three cases, analysis of 
the tinned food confirmed vitamin D concentration to be 
between 11 and 13.5 times the upper nutritional maxi-
mum. As chicken breast/fillets are naturally low in vita-
min D (0–216 IU/kg),10 this suggests either contamination 
of the ingredients used in the manufacturing process of 
the food or supplementation of additives not stated on 
the label. As both vitamin D2 and vitamin D3 were 
increased in the food analysis it suggests there was con-
tamination or supplementation of both forms. It is likely 
that high levels of vitamin D3 contributed to a greater 
extent to the hypervitaminosis D than high vitamin D2 Ta
b
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levels as cats utilise vitamin D3 with greater efficiency to 
maintain plasma 25-hydroxyvitamin D concentrations.11 
It is important to note that the food label should state the 
vitamin D concentration at the end of the shelf-life of the 
product and therefore higher values may be expected if 
analysed before this date. Despite this caveat, the levels 
in the food fed to the cats were still higher than the nutri-
tional maximum.
The dietary calcium and phosphate concentration 
and calcium:phosphate ratios were very low when ana-
lysed in the tinned food (case 2 and 3). When consider-
ing the recommended requirements for a growing cat 
(see Table 8), the calcium concentration of the diet was 
approximately 30 times below the requirement and the 
phosphate concentration approximately 1.7 times below 
the requirement. Low calcium content or altered 
calcium:phosphate ratio of the diet can be associated 
with nutritional secondary hyperparathyroidism, in 
which low calcium stimulates production of PTH from 
the parathyroid gland. In all three cases, PTH concentra-
tion was at the low end of the RI or below it and not sug-
gestive of nutritional secondary hyperparathyroidism as 
expected in the case of vitamin D toxicosis. Nutritional 
secondary hyperparathyroidism generally develops 
Table 6 Parathyroid hormone (PTH), vitamin D metabolite and calcitonin results in hypercalcaemic male (case 2) and 
female (case 3) 5-month-old British Shorthair cats
Case 2 Case 3 RI
PTH (pmol/l) <0.2 <0.2 0.3–4.0*
1,25 Dihydroxyvitamin D (calcitriol; pmol/l) 436.4 406.3 192–317†
25-Hydroxyvitamin D (calcidiol; nmol/l) 553.4 242.5 126–163†
Calcitonin (ng/l) <0.9 <0.9 <0.9–3.2‡
Ionised calcium (mmol/l) 1.94 1.91 1.10–1.40
*Reference interval (RI) taken from Pineda et al7
†RI taken from Tomsa et al,6 which was derived in healthy age-matched control cats
‡RI taken from Pineda et al8
Table 7 Dietary analysis of the complementary natural tinned kitten food fed to two 5-month-old British Shorthair cats 
(case 2 and 3) as part of their diet
Vitamin D3
(IU/kg)
Vitamin D2
(IU/kg)
Vitamin D2 and D3 
combined (IU/kg)
Calcium
(g/kg)
Phosphate
(g/kg)
Calcium: 
phosphate ratio
Tinned kitten food (wet 
weight as fed)
53,500 14,500 68,000 0.058 0.835 0.069
Tinned kitten food (DM 
basis)*
318,325 86,275 404,600 0.345 4.968 0.069
See Table 8 for recommended concentrations
*Actual dry matter (DM) content (16.8%) determined in an independent external commercial laboratory (ALS Food and Pharmaceutical, Ely, UK)
Table 8 European pet food industry (FEDIAF) nutritional guidelines for complete and complementary pet foods12
Minimum 
recommended 
(adults)
Minimum 
recommended 
(growth)
Maximum 
nutritional 
(adult)*
Maximum 
nutritional 
(growth)*
Legal limit†
Calcium (g/kg DM) 5.9 10.0 NA NA NA
Phosphate (g/kg DM) 5.0 8.4 NA NA NA
Calcium:phosphate ratio 1:1 1:1 2:1 1.5:1 NA
Vitamin D (IU/kg DM)‡ 250 750 30000 30000 2270
*Maximum nutritional limit is the maximum level of nutrition in a complete pet food that, based on scientific data, has not been associated with 
adverse effects in healthy cats
†The legal limit (European Union regulation 1831/2003) applies to all life stages. It only applies when the vitamin is a declared additive. If the 
nutrient is derived exclusively from the feed materials, the legal maximum does not apply and instead the nutritional maximum should be taken 
into account
‡Vitamin D is combined ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) content
DM = dry matter; NA = not available
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with chronic calcium deficiency and it is possible that, 
had the cats been fed the diet in the longer term, clinical 
evidence of nutritional secondary hyperparathyroidism 
may have developed if, indeed, the source of high vita-
min D was due to an inadvertent one-off contamination 
as opposed to excessive supplementation. However, the 
development of nutritional secondary hyperparathy-
roidism seems unlikely in the presence of high vitamin D 
as plasma concentrations of calcium will be high and cal-
citriol has a negative influence on PTH production.
A parallel increase in calcium and phosphate concen-
tration in patients with hypervitaminosis D might be 
expected. It is therefore interesting that only cases 2 and 
3 were hyperphosphataemic (although the influence of 
age must be considered when interpreting this result) 
and highlights that hypervitaminosis D should be 
included as a differential diagnosis for cases with hyper-
calcaemia even if the serum phosphate is normal.
The clinical signs in case 1 could all be explained by 
the hypercalcaemia; the coughing and retching were 
likely due to pulmonary mineralisation, although the 
Mycoplasma species found on BAL PCR and mild airway 
inflammation may also have played a role; the pica and 
melaena were likely due to gastrointestinal bleeding 
from gastrointestinal wall mineralisation,13 and this 
would be consistent with the hyperechoic gastric wall 
identified on ultrasound examination. The lethargy, 
inappetence and polyuria/polydipsia in cases 2 and 3 
were all likely secondary to the hypercalcaemia. Of inter-
est was the finding that case 1 not only had the highest 
serum concentration of vitamin D metabolites and most 
likely ingested a greater amount of the food, but also 
presented with the more severe clinical signs.
As vitamin D is a fat-soluble vitamin, it will persist in 
the body for weeks to months following toxicity, with 
the decline in calcitriol concentration thought to be more 
rapid than for calcidiol. It was not possible to perform 
serial measurements of vitamin D in any of the cats; 
however, the relatively rapid resolution of clinical signs 
and return to normocalcaemia in all three cats following 
withdrawal of the suspected source of vitamin D (19 
days for case 1, 18 days for case 2 and 5 days for case 3) 
and the absence of relapse of hypercalcaemia after treat-
ment discontinuation suggests that either the clinical 
effects of the toxicity were not prolonged or that the sup-
portive management was effective. Furthermore, the 
mineralisation present on the initial CT scan in case 1 
had improved at repeat CT imaging (day 31 following 
initial presentation; data not shown). The time taken for 
complete resolution of the mineralisation could not be 
ascertained as further imaging was not performed.
Calcitonin concentrations were measured in case 2 
and 3. Calcitonin is produced from C cells in the thyroid 
gland in response to hypercalcaemia and it inhibits oste-
oclastic activity, decreasing bone resorption. In cases of 
hypercalcaemia, calcitonin concentration would be 
expected to be elevated with the effect of decreasing cal-
cium concentrations; however, in cases 2 and 3 calcitonin 
was not increased. A previous study of cats in which 
hypercalcaemia was induced experimentally found a 
subset of cats that did not increase their calcitonin con-
centration in response to ionised hypercalcaemia, and 
these cats were termed non-responders.8 It is possible 
that cases 2 and 3 were also ‘non-responders’. The under-
lying mechanism for this lack of increase in calcitonin 
concentration is unknown and may be related to muta-
tions in the calcium-sensing receptor in the parathyroid 
gland. Further studies exploring calcitonin response in 
hypercalcaemic cats are warranted.
A limitation of this case study is that analysis of other 
foods fed in cases 2 and 3 was not performed owing to 
the extensive variability and high cost of analysis, and 
also suspicion related to the diet raised in case 1.
Conclusions
This case series highlights the importance of considering 
nutritional hypervitaminosis D as a differential diagnosis 
in cats with hypercalcaemia even if the serum phosphate 
is not elevated. Measurement of vitamin D metabolites is 
recommended in investigating such cases. In addition, it 
demonstrates the importance of obtaining a thorough 
dietary history and performing dietary analysis in cases 
of suspected vitamin D toxicity even when a single diet is 
not fed exclusively or when the diet is marketed as a nat-
ural, complementary product without added vitamin D.
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